Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
B

Banyan Corp
OTC:BNYN

Watchlist Manager
Banyan Corp
OTC:BNYN
Watchlist
Price: 0.0002 USD Market Closed
Market Cap: $290.6k
Write Note Create Alert Ask AI

Relative Value

BNYN latest financial reports are more than 14 years old.
BNYN doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of BNYN.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BNYN Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

P/S
View Details
P/E
View Details
P/OCF
View Details
P/FCFE
View Details
P/B
View Details
EV/S
View Details
EV/GP
View Details
EV/EBITDA
View Details
EV/EBIT
View Details
EV/OCF
View Details
EV/FCFF
View Details
EV/IC
View Details

Multiples Across Competitors

BNYN Competitors Multiples
Banyan Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Banyan Corp
OTC:BNYN
290.6k USD 0.1 -0.1 -1.9 -1.9
US
CVS Health Corp
NYSE:CVS
99.7B USD 0.3 212.6 14 14
US
Cigna Corp
NYSE:CI
78.2B USD 0.3 12.7 0 0
US
Cigna Group
XMUN:CGN
63.5B EUR 0.3 12.2 7.8 9.9
DE
Fresenius SE & Co KGaA
XETRA:FRE
27.9B EUR 1.2 24.3 10.6 16.2
DE
Fresenius Medical Care AG
XMUN:FME
23.9B EUR 1.2 33.1 10.4 22.3
US
Laboratory Corporation of America Holdings
NYSE:LH
23B USD 1.7 26.9 14.4 20.2
US
Quest Diagnostics Inc
NYSE:DGX
21.3B USD 2 22.4 12.2 16.5
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.8B EUR 0.6 16.2 6.4 13.7
US
Guardant Health Inc
NASDAQ:GH
12.6B USD 14.1 -31.8 -33.6 -30.5
US
DaVita Inc
NYSE:DVA
10B USD 0.7 12.9 7.3 10
P/E Multiple
Earnings Growth PEG
US
B
Banyan Corp
OTC:BNYN
Average P/E: 41.5
Negative Multiple: -0.1 		N/A N/A
US
CVS Health Corp
NYSE:CVS
212.6
32%
6.6
US
Cigna Corp
NYSE:CI
12.7
39%
0.3
US
C
Cigna Group
XMUN:CGN
12.2
39%
0.3
DE
Fresenius SE & Co KGaA
XETRA:FRE
24.3
71%
0.3
DE
Fresenius Medical Care AG
XMUN:FME
33.1
37%
0.9
US
Laboratory Corporation of America Holdings
NYSE:LH
26.9
30%
0.9
US
Quest Diagnostics Inc
NYSE:DGX
22.4
14%
1.6
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
16.2
37%
0.4
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -31.8 N/A N/A
US
DaVita Inc
NYSE:DVA
12.9
6%
2.2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
B
Banyan Corp
OTC:BNYN
Average EV/EBITDA: 10.4
Negative Multiple: -1.9 		N/A N/A
US
CVS Health Corp
NYSE:CVS
14
25%
0.6
US
Cigna Corp
NYSE:CI
Not Available N/A N/A
US
C
Cigna Group
XMUN:CGN
7.8
4%
2
DE
Fresenius SE & Co KGaA
XETRA:FRE
10.6
14%
0.8
DE
Fresenius Medical Care AG
XMUN:FME
10.4
10%
1
US
Laboratory Corporation of America Holdings
NYSE:LH
14.4
16%
0.9
US
Quest Diagnostics Inc
NYSE:DGX
12.2
8%
1.5
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
6.4
10%
0.6
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -33.6 N/A N/A
US
DaVita Inc
NYSE:DVA
7.3
4%
1.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
B
Banyan Corp
OTC:BNYN
Average EV/EBIT: 15.3
Negative Multiple: -1.9 		N/A N/A
US
CVS Health Corp
NYSE:CVS
14
19%
0.7
US
Cigna Corp
NYSE:CI
Not Available N/A N/A
US
C
Cigna Group
XMUN:CGN
9.9
5%
2
DE
Fresenius SE & Co KGaA
XETRA:FRE
16.2
20%
0.8
DE
Fresenius Medical Care AG
XMUN:FME
22.3
25%
0.9
US
Laboratory Corporation of America Holdings
NYSE:LH
20.2
27%
0.7
US
Quest Diagnostics Inc
NYSE:DGX
16.5
11%
1.5
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13.7
25%
0.5
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -30.5 N/A N/A
US
DaVita Inc
NYSE:DVA
10
4%
2.5

See Also

Summary
BNYN intrinsic value, competitors valuation, and company profile.
DCF Valuation
BNYN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BNYN stock valuation using valuation multiples.
Wall Street Estimates
BNYN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BNYN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 315,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.